Leo Kesner

791 total citations
34 papers, 655 citations indexed

About

Leo Kesner is a scholar working on Molecular Biology, Cell Biology and Clinical Biochemistry. According to data from OpenAlex, Leo Kesner has authored 34 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cell Biology and 6 papers in Clinical Biochemistry. Recurrent topics in Leo Kesner's work include Metabolism and Genetic Disorders (6 papers), Calpain Protease Function and Regulation (5 papers) and Analytical Chemistry and Chromatography (5 papers). Leo Kesner is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Calpain Protease Function and Regulation (5 papers) and Analytical Chemistry and Chromatography (5 papers). Leo Kesner collaborates with scholars based in United States. Leo Kesner's co-authors include Phillip C. Chan, Edward Muntwyler, Alfred Stracher, Getaw Worku Hassen, John T. Brandt, Nelson Fausto, Foroozan Mokhtarian, H. Leon Bradlow, Myung Hee Chung and H. Ghadimi and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

Leo Kesner

34 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo Kesner United States 15 264 116 111 90 63 34 655
T. Hallinan United Kingdom 18 503 1.9× 106 0.9× 116 1.0× 94 1.0× 89 1.4× 59 844
C. K. Ramakrishna Kurup India 17 511 1.9× 148 1.3× 81 0.7× 186 2.1× 55 0.9× 66 821
Masazumi Takeshita Japan 17 408 1.5× 89 0.8× 124 1.1× 186 2.1× 94 1.5× 50 843
Jørgen Jacobsen Denmark 13 483 1.8× 72 0.6× 305 2.7× 125 1.4× 67 1.1× 27 916
S Gebicki Australia 6 413 1.6× 69 0.6× 65 0.6× 157 1.7× 81 1.3× 8 741
Louise B. Bradley United States 4 677 2.6× 132 1.1× 177 1.6× 181 2.0× 103 1.6× 5 1.1k
L Clejan United States 17 379 1.4× 52 0.4× 47 0.4× 59 0.7× 23 0.4× 36 652
Hans Moellering Germany 6 251 1.0× 72 0.6× 54 0.5× 79 0.9× 37 0.6× 12 559
Otto Walaas Norway 19 585 2.2× 47 0.4× 150 1.4× 168 1.9× 93 1.5× 65 1.1k
T. Nagasaki Japan 11 502 1.9× 79 0.7× 58 0.5× 145 1.6× 199 3.2× 28 1.3k

Countries citing papers authored by Leo Kesner

Since Specialization
Citations

This map shows the geographic impact of Leo Kesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Kesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Kesner more than expected).

Fields of papers citing papers by Leo Kesner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Kesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Kesner. The network helps show where Leo Kesner may publish in the future.

Co-authorship network of co-authors of Leo Kesner

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Kesner. A scholar is included among the top collaborators of Leo Kesner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Kesner. Leo Kesner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassen, Getaw Worku, Leo Kesner, Alfred Stracher, et al.. (2018). Effects of Novel Calpain Inhibitors in Transgenic Animal Model of Parkinson’s disease/dementia with Lewy bodies. Scientific Reports. 8(1). 18083–18083. 23 indexed citations
2.
Hassen, Getaw Worku, Leo Kesner, Alfred Stracher, & Abraham Shulman. (2017). Calpain Inhibition: A Potential Therapeutic Target for Nneurodegenerative and Neuromuscular Disorders. 3. 33. 3 indexed citations
3.
Kesner, Leo, Steven Roth, Pearl S. Rosenbaum, et al.. (2011). A novel calpain inhibitor for treatment of transient retinal ischemia in the rat. Neuroreport. 22(13). 633–636. 12 indexed citations
4.
Hassen, Getaw Worku, et al.. (2008). Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis. Brain Research. 1236. 206–215. 32 indexed citations
5.
Hassen, Getaw Worku, et al.. (2006). A novel calpain inhibitor for the treatment of acute experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 180(1-2). 135–146. 29 indexed citations
6.
Rogelj, Snezna, et al.. (2000). Enzyme Destruction by a Protease Contaminant in Bacitracin. Biochemical and Biophysical Research Communications. 273(3). 829–832. 22 indexed citations
7.
Medina, Verónica Sánchez de, Leo Kesner, & A. Stracher. (1993). Purification of Nonantibiotic Insulinase Inhibitors from Bacitracin. Biochemical Medicine and Metabolic Biology. 49(2). 255–264. 7 indexed citations
8.
Kesner, Leo, et al.. (1990). Cyst Fluid Proteases. Annals of the New York Academy of Sciences. 586(1). 198–203. 7 indexed citations
9.
Kwon, N S, Phillip C. Chan, & Leo Kesner. (1990). Inactivation of α1-proteinase inhibitor by Cu(II) and hydrogen peroxide. Inflammation Research. 29(3-4). 388–393. 4 indexed citations
10.
Kesner, Leo. (1989). Experiences in presenting nutrition in basic science courses--SUNY/Health Science Center at Brooklyn.. PubMed. 65(9). 924–7; discussion 937. 1 indexed citations
11.
Chan, Phillip C., et al.. (1985). Peroxidation of lysozyme treated with Cu(II) and hydrogen peroxide. Inorganica Chimica Acta. 107(4). 253–258. 7 indexed citations
12.
Chan, Phillip C., et al.. (1982). Copper(II)‐catalyzed lipid peroxidation in liposomes and erythrocyte membranes. Lipids. 17(5). 331–337. 116 indexed citations
13.
Chan, Phillip C. & Leo Kesner. (1980). Copper (II) complex-catalyzed oxidation of NADH by hydrogen peroxide. Biological Trace Element Research. 2(3). 159–174. 13 indexed citations
14.
Kesner, Leo, et al.. (1977). Gluconeogenesis in the rat renal cortex after warm ischemia and hypothermic storage. Cryobiology. 14(3). 332–336. 1 indexed citations
15.
Kesner, Leo, et al.. (1975). Determination of Orotic and Dihydroorotic Acids in Biological Fluids and Tissues. Clinical Chemistry. 21(3). 353–355. 40 indexed citations
16.
Ghadimi, H., et al.. (1971). Biosynthesis of saccharopine and pipecolic acid from l- and dl-14C-lysine by human and dog liver in vitro. Biochemical Medicine. 5(1). 56–66. 17 indexed citations
17.
Muntwyler, Edward, et al.. (1970). Amino acid content of muscle and plasma with altered pH. Metabolism. 19(2). 179–186. 10 indexed citations
18.
Kesner, Leo. (1965). The Effect of Ammonia Administration on Orotic Acid Excretion in Rats. Journal of Biological Chemistry. 240(4). 1722–1724. 54 indexed citations
19.
Kesner, Leo, et al.. (1964). Studies on the hydrolytic action of pronase on derivatized and non-derivatized proteins. Biochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects. 85(3). 435–440. 8 indexed citations
20.
Kesner, Leo, et al.. (1963). Automatic Column Chromatography of Ether and Water-Soluble 2,4-Dinitrophenyl-Derivatives of Amino Acids, Peptides, and Amines.. Analytical Chemistry. 35(1). 83–89. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026